EARLY BIRD DISCOUNT! Register by February 5, 2017 to receive 20% off your registration!
Or register 3 for the price of 2 with the coupon code rcdvb!
registration button

10th Diabetes Drug Discovery & Development

7th Diabetes Partnering & Deal-Making
GTCbio offers comprehensive sponsorship packages for all our meetings, including presentation opportunities, exhibit and booth space, as well as the event delegate list. All our packages can be customized to meet your company's budget. For information, please contact:

Amber Kempf
626-256-6405 x110
amber.kempf [at] gtcbio.com

GTCbio encourages attendees to showcase their research at the conference by presenting a poster. The top 2-3 submitted posters will also be selected to give short oral presentations as part of the meeting program. Abstracts will be accepted until February 5, 2017; slots fill up quickly so submit yours online ASAP!
"The GTC Diabetes Summit converged stakeholders in translational development, discovery, commercialization and care delivery in a diabetes-focused conference that stimulated discussion, ideas, and networking so critical for advancing innovation to address the current global challenges. It was a high-value, engaging conference.”
- CEO, Exsulin

Speakers | Agenda | Venue | Sponsors | Poster Submissions

Dear Colleague,

GTCbio and the advisory board would like to invite you to the 2017 Diabetes Summit to be held April 5-7, 2017 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:

Conference 1: 10th Diabetes Drug Discovery & Development Conference
  1. Going Back to the Basics - Street Light Effect
  2. Novel Therapeutic Targets & Strategies
  3. Translation to The Clinic: What's in the Pipeline

Joint: Plenary Session :
  1. Where do We Stand with Stem Cell Therapy in Diabetes?

Conference 2: 7th Diabetes Partnering & Deal-Making Conference
  1. Current Trends and Future Projections for Investments
  2. Partnering and Licensing Opportunities
  3. Devices and Digital Aids in Diabetes Management
  4. Investment in Disease Modifying Therapies
  5. Patient Entrepreneur Panel
  6. Biotech Showcase: Emerging Pipelines

Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.

We look forward to seeing you at the conference!

Best regards,

The 2017 Advisory Committee

2017 Advisory Board Members
Robert Geho, Diasome Pharmaceuticals Inc
Zan Fleming, Kinexum
Alan Cherrington, Vanderbilt
Nirja Patel, ALPCO Diagnostics
Vivek Shenoy, Renovo Solutions









Attend all GTCbio Conferences for one year for only $4,995 ($2,495 for academic and government).
Click here to sign up!

diabetes-summit Overview